Cargando…

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy

The tumor suppressor p53 is a well-known cellular guardian of genomic integrity that blocks cell cycle progression or induces apoptosis upon exposure to cellular stresses. However, it is unclear how the remaining activities of p53 are regulated after the abrogation of these routine activities. Ferro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Le, Hou, Ningning, Chen, Bing, Kan, Chengxia, Han, Fang, Zhang, Jingwen, Sun, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171069/ https://www.ncbi.nlm.nih.gov/pubmed/35685623 http://dx.doi.org/10.3389/fphar.2022.908772

Ejemplares similares

Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells
por: Qu, Na, et al.
Publicado: (2022)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology
por: Wani, Revati, et al.
Publicado: (2014)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
por: Li, Shengqiang, et al.
Publicado: (2022)

Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases
por: Li, Yun, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code
por: Wang, Yanfeng, et al.
Publicado: (2021)

Surf the Post-translational Modification Network of p53 Regulation
por: Gu, Bo, et al.
Publicado: (2012)

Translational Pharmacology
por: Stewart, Alastair G.
Publicado: (2017)

Corrigendum: Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
por: Li, Shengqiang, et al.
Publicado: (2022)

Online Education Plight and Countermeasures for MBBS in Chinese Regional Medical Schools Based on the OBE Concept During COVID-19 Pandemic
por: Liang, Yan, et al.
Publicado: (2022)

Managing the complexity of communication: regulation of gap junctions by post-translational modification
por: Axelsen, Lene N., et al.
Publicado: (2013)

Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes
por: Laedermann, Cedric J., et al.
Publicado: (2015)

Ferroptosis as a promising therapeutic strategy for melanoma
por: Ta, Na, et al.
Publicado: (2023)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

The Application of Cell-Free Protein Synthesis in Genetic Code Expansion for Post-translational Modifications
por: Venkat, Sumana, et al.
Publicado: (2019)

Reconstitution of Mdm2-Dependent Post-Translational Modifications of p53 in Yeast
por: Di Ventura, Barbara, et al.
Publicado: (2008)

Editorial: Women in translational pharmacology: 2021
por: Vengeliene, Valentina, et al.
Publicado: (2023)

Progress on structural modification of Tetrandrine with wide range of pharmacological activities
por: Mo, Liuying, et al.
Publicado: (2022)

Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes
por: Zhu, Jiawei, et al.
Publicado: (2020)

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021)

Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer
por: Huang, Chen, et al.
Publicado: (2022)

Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells
por: Zhang, S, et al.
Publicado: (2004)

The role of p53 in liver fibrosis
por: Yu, Siyu, et al.
Publicado: (2022)

Irisin protects against obesity-related chronic kidney disease by regulating perirenal adipose tissue function in obese mice
por: Han, Fang, et al.
Publicado: (2022)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Post-translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature
por: Clark, James S., et al.
Publicado: (2022)

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
por: Qu, Na, et al.
Publicado: (2022)

Ferroptosis and the bidirectional regulatory factor p53
por: Xu, Ren, et al.
Publicado: (2023)

Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)

Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications
por: Huang, Xing, et al.
Publicado: (2022)

Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer
por: Lu, Ling, et al.
Publicado: (2022)

Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
por: Zhang, Weifen, et al.
Publicado: (2018)

The Role of Ferroptosis in Cancer Development and Treatment Response
por: Lu, Bin, et al.
Publicado: (2018)

NMNAT promotes glioma growth through regulating post-translational modifications of P53 to inhibit apoptosis
por: Liu, Jiaqi, et al.
Publicado: (2021)

Editorial: Model-informed drug development and evidence-based translational pharmacology
por: Zhao, Jinxin, et al.
Publicado: (2022)

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases
por: Cui, Can, et al.
Publicado: (2022)

An Integrative Pharmacology-Based Pattern to Uncover the Pharmacological Mechanism of Ginsenoside H Dripping Pills in the Treatment of Depression
por: Zhao, Libin, et al.
Publicado: (2021)

Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
por: Chen, Weixiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u072v453t4beee8t238vuuldck